News

  1. Not all labs experiencing testing lag

    November 23, 2020 - Aegis Sciences was featured on WSMV News4 Nashville - view clip NASHVILLE, TN (WSMV) - There is a nationwide shortage of the reagents…

    November 23, 2020 - Aegis Sciences was featured on WSMV News4 Nashville - view clip NASHVILLE, TN (WSMV) - There is a nationwide shortage of the reagents that labs need for COVID tests, but not all labs are having problems. “Right now, our average turnaround time is 14.2 hours,” Dr. Matthew Hardison, Aegis Labs, said. That’s for the most reliable kind of test, the PCR test. Hardison said the turnaround…

  2. Aegis Sciences Corporation Launches Combined Test for SARS-CoV-2 and Influenza A/B Virus

    Nashville, Tennessee (November 16, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

    Nashville, Tennessee (November 16, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, has launched a combined test for SARS-CoV-2 and influenza A/B virus for individuals suspected of respiratory viral infection consistent with COVID-19. Reducing the spread of respiratory illnesses,…

  3. Oral Fluid Testing Capabilities Expanded to Identify Pertinent Drug Interactions

    Nashville, Tennessee (November 9, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

    Nashville, Tennessee (November 9, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services, has launched new oral fluid testing enhancements. To better support healthcare customers during the pandemic, Aegis now offers InterACT Rx™ testing for oral fluid specimens. InterACT Rx is a definitive, mass spectrometry…

  4. Innovation and Adaptability: How Family Service League and Aegis Sciences Corporation collaborate to assist clients during the pandemic

    Nashville, Tennessee (October 27, 2020) – The COVID-19 pandemic has brought significant challenges to both healthcare systems and public health.  Social…

    Nashville, Tennessee (October 27, 2020) – The COVID-19 pandemic has brought significant challenges to both healthcare systems and public health.  Social distancing, disruption of healthcare services, and unemployment are affecting at-risk populations at a high rate exacerbating behavioral health problems and increasing adverse health outcomes.  Although COVID-19 pandemic measures impact the entire…

  5. Aegis Sciences Corporation announces it has been awarded $6.6 million NIH grant to rapidly expand COVID-19 Test Capacity

    Capacity for 60,000 tests a day expected by September 30 with most results available within 24 hours Nashville, Tennessee (September 2, 2020) – Aegis…

    Capacity for 60,000 tests a day expected by September 30 with most results available within 24 hours Nashville, Tennessee (September 2, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers has been selected to participate in the National Institutes of Health Rapid Acceleration of Diagnostics…

  6. Aegis Sciences Corporation and QURE Announce Groundbreaking Results from InterACT Rx™ Study Demonstrating Objective Identification of Drug-drug Interactions Linked to Improved Patient Outcomes

    Physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by DDIs resulting in improved patient outcomes. SAN FRANCISCO…

    Physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by DDIs resulting in improved patient outcomes. SAN FRANCISCO and NASHVILLE, Tenn., Sept. 15, 2021 - The results of the prospective randomized DECART-2 study were released on July 15, 2021 in the journal, Diagnostics. The research, conducted among 331 patients of primary care physicians (PCP), showed that InterACT…

  7. Aegis now a Blue Cross Blue Shield of Texas participating provider

    NASHVILLE, TN (September 1, 2020) - Aegis Sciences Corporation is pleased to announce that effective September 1, 2020 we will be a participating laboratory…

    NASHVILLE, TN (September 1, 2020) - Aegis Sciences Corporation is pleased to announce that effective September 1, 2020 we will be a participating laboratory provider with Blue Cross and Blue Shield in Texas for Commercial, Managed Medicare and Managed Medicaid. Our product participation with Blue Cross Blue Shield Texas will allow referring physicians to utilize Aegis’ laboratory services and members…

  8. HHS Announces collaboration with Aegis Sciences Corporation to ramp high quality COVID-19 RT-PCR testing with fast results

    Today, the U.S. Department of Health and Human Services announced combined investments of $6.5 million in two commercial diagnostic laboratories to expand…

    Today, the U.S. Department of Health and Human Services announced combined investments of $6.5 million in two commercial diagnostic laboratories to expand capacity to conduct up to 4 million additional SARS-CoV-2 per month. SARS-CoV-2 is the virus that causes COVID-19.

  9. Aegis Sciences provides & expands COVID-19 testing ‘smartly’ – patient-centric, medically-focused

    NASHVILLE, TN (WSMV) - The number of people getting testing for coronavirus nationwide is growing rapidly, which is causing the biggest laboratories in…

    NASHVILLE, TN (WSMV) - The number of people getting testing for coronavirus nationwide is growing rapidly, which is causing the biggest laboratories in Tennessee to expand to fit the growing needs.

  10. Aegis Sciences Corporation Announces National Launch of Expanded Novel Psychoactive Substance Testing

    NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication…

    NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, has launched new testing options which allow providers to test for various classes of novel psychoactive substances (NPS). Along with the addition of new drugs to Aegis’ synthetic cannabinoid…